CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 289 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $687,196 | -10.3% | 21,151 | -30.5% | 0.06% | -7.2% |
| Q1 2024 | $766,305 | -38.3% | 30,421 | -20.4% | 0.07% | -41.5% |
| Q4 2023 | $1,241,061 | +83.0% | 38,210 | +53.5% | 0.12% | +61.6% |
| Q3 2023 | $678,046 | +51.0% | 24,887 | +23.3% | 0.07% | +46.0% |
| Q2 2023 | $449,072 | +2.7% | 20,183 | 0.0% | 0.05% | -5.7% |
| Q1 2023 | $437,164 | -10.8% | 20,183 | -16.3% | 0.05% | -14.5% |
| Q4 2022 | $489,938 | +169.2% | 24,123 | +123.2% | 0.06% | +195.2% |
| Q2 2020 | $182,000 | +42.2% | 10,807 | 0.0% | 0.02% | +16.7% |
| Q1 2020 | $128,000 | -56.6% | 10,807 | -33.9% | 0.02% | -75.3% |
| Q4 2017 | $295,000 | +104.9% | 16,359 | -31.6% | 0.07% | +121.2% |
| Q2 2015 | $144,000 | – | 23,901 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
| Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
| Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
| S&T BANK/PA | 347,260 | $7,727 | 1.39% |
| FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
| Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
| Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |